Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Building community resilience in a context of climate change: The role of social capital

Cultural Transformation in the Geoscience Community AND Program Evaluation

Bedinger M, Carmen E, Fazey I, Ross H.
GSID: VBIvJoROErQJ
E Carmen, I Fazey, H Ross, M Bedinger, FM Smith… - Ambio, 2022 - Springer

Social capital is considered important for resilience across social levels, including communities, yet insights are scattered across disciplines. This meta-synthesis of 187 studies examines conceptual and empirical understandings of how social capital relates to resilience, identifying implications for community...

Cite
Carmen, E., Fazey, I., Ross, H., Bedinger, M., Smith, F. M., Prager, K., ... & Morrison, D. (2022). Building community resilience in a context of climate change: The role of social capital. Ambio, 1-17.
Carmen, Esther, et al. "Building community resilience in a context of climate change: The role of social capital." Ambio (2022): 1-17.
Copy Download .nbib Format: MLA
Driving with music: cognitive-behavioural implications.

Ergonomics

Bedinger M.
PMID: 27007752
Ergonomics. 2016 Oct;59(10):1403-1404. doi: 10.1080/00140139.2016.1143678. Epub 2016 Mar 23.

No abstract available.

Cite
Bedinger M. Driving with music: cognitive-behavioural implications. Ergonomics. 2016;59(10):1403-1404doi: 10.1080/00140139.2016.1143678.
Bedinger, M. (2016). Driving with music: cognitive-behavioural implications. Ergonomics, 59(10), 1403-1404. https://doi.org/10.1080/00140139.2016.1143678
Bedinger, Melissa. "Driving with music: cognitive-behavioural implications." Ergonomics vol. 59,10 (2016): 1403-1404. doi: https://doi.org/10.1080/00140139.2016.1143678
Bedinger M. Driving with music: cognitive-behavioural implications. Ergonomics. 2016 Oct;59(10):1403-1404. doi: 10.1080/00140139.2016.1143678. Epub 2016 Mar 23. PMID: 27007752.
Copy Download .nbib Format: NLM
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds.

Journal for immunotherapy of cancer

van Diest E, Hernández López P, Meringa AD, Vyborova A, Karaiskaki F, Heijhuurs S, Gumathi Bormin J, van Dooremalen S, Nicolasen MJT, Gatti LCDE, Johanna I, Straetemans T, Sebestyén Z, Beringer DX, Kuball J.
PMID: 34815357
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003850.

No abstract available.

Cite
van Diest E, Hernández López P, Meringa AD, et al. Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. J Immunother Cancer. 2021;9(11)doi: 10.1136/jitc-2021-003850.
van Diest, E., Hernández López, P., Meringa, A. D., Vyborova, A., Karaiskaki, F., Heijhuurs, S., Gumathi Bormin, J., van Dooremalen, S., Nicolasen, M. J. T., Gatti, L. C. D. E., Johanna, I., Straetemans, T., Sebestyén, Z., Beringer, D. X., & Kuball, J. (2021). Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. Journal for immunotherapy of cancer, 9(11), . https://doi.org/10.1136/jitc-2021-003850
van Diest, Eline, et al. "Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds." Journal for immunotherapy of cancer vol. 9,11 (2021). doi: https://doi.org/10.1136/jitc-2021-003850
van Diest E, Hernández López P, Meringa AD, Vyborova A, Karaiskaki F, Heijhuurs S, Gumathi Bormin J, van Dooremalen S, Nicolasen MJT, Gatti LCDE, Johanna I, Straetemans T, Sebestyén Z, Beringer DX, Kuball J. Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003850. PMID: 34815357.
Copy Download .nbib Format: NLM
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells.

Molecular therapy. Methods & clinical development

Kierkels GJJ, van Diest E, Hernández-López P, Scheper W, de Bruin ACM, Frijlink E, Aarts-Riemens T, van Dooremalen SFJ, Beringer DX, Oostvogels R, Kramer L, Straetemans T, Uckert W, Sebestyén Z, Kuball J.
PMID: 34514030
Mol Ther Methods Clin Dev. 2021 Jun 24;22:388-400. doi: 10.1016/j.omtm.2021.06.011. eCollection 2021 Sep 10.

T cell engineering strategies offer cures to patients and have entered clinical practice with chimeric antibody-based receptors; αβT cell receptor (αβTCR)-based strategies are, however, lagging behind. To allow a more rapid and successful translation to successful concepts also using...

Cite
Kierkels GJJ, van Diest E, Hernández-López P, et al. Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Mol Ther Methods Clin Dev. 2021;22:388-400doi: 10.1016/j.omtm.2021.06.011.
Kierkels, G. J. J., van Diest, E., Hernández-López, P., Scheper, W., de Bruin, A. C. M., Frijlink, E., Aarts-Riemens, T., van Dooremalen, S. F. J., Beringer, D. X., Oostvogels, R., Kramer, L., Straetemans, T., Uckert, W., Sebestyén, Z., & Kuball, J. (2021). Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Molecular therapy. Methods & clinical development, 22388-400. https://doi.org/10.1016/j.omtm.2021.06.011
Kierkels, Guido J J, et al. "Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells." Molecular therapy. Methods & clinical development vol. 22 (2021): 388-400. doi: https://doi.org/10.1016/j.omtm.2021.06.011
Kierkels GJJ, van Diest E, Hernández-López P, Scheper W, de Bruin ACM, Frijlink E, Aarts-Riemens T, van Dooremalen SFJ, Beringer DX, Oostvogels R, Kramer L, Straetemans T, Uckert W, Sebestyén Z, Kuball J. Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Mol Ther Methods Clin Dev. 2021 Jun 24;22:388-400. doi: 10.1016/j.omtm.2021.06.011. eCollection 2021 Sep 10. PMID: 34514030; PMCID: PMC8411211.
Copy Download .nbib Format: NLM
Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women.

EClinicalMedicine

Bekker LG, Li S, Pathak S, Tolley EE, Marzinke MA, Justman JE, Mgodi NM, Chirenje M, Swaminathan S, Adeyeye A, Farrior J, Hendrix CW, Piwowar-Manning E, Richardson P, Eshelman SH, Redinger H, Williams P, Sista ND.
PMID: 32280940
EClinicalMedicine. 2020 Apr 06;21:100303. doi: 10.1016/j.eclinm.2020.100303. eCollection 2020 Apr.

BACKGROUND: Daily oral TDF/FTC is protective against HIV infection when used for pre-exposure prophylaxis (PrEP). However, daily adherence to oral PrEP is difficult for many; therefore, finding alternative PrEP strategies remains a priority. HPTN 076 evaluated the long-acting injectable...

Cite
Bekker LG, Li S, Pathak S, et al. Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women. EClinicalMedicine. 2020;21:100303doi: 10.1016/j.eclinm.2020.100303.
Bekker, L. G., Li, S., Pathak, S., Tolley, E. E., Marzinke, M. A., Justman, J. E., Mgodi, N. M., Chirenje, M., Swaminathan, S., Adeyeye, A., Farrior, J., Hendrix, C. W., Piwowar-Manning, E., Richardson, P., Eshelman, S. H., Redinger, H., Williams, P., Sista, N. D. (2020). Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women. EClinicalMedicine, 21100303. https://doi.org/10.1016/j.eclinm.2020.100303
Bekker, L G, et al. "Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women." EClinicalMedicine vol. 21 (2020): 100303. doi: https://doi.org/10.1016/j.eclinm.2020.100303
Bekker LG, Li S, Pathak S, Tolley EE, Marzinke MA, Justman JE, Mgodi NM, Chirenje M, Swaminathan S, Adeyeye A, Farrior J, Hendrix CW, Piwowar-Manning E, Richardson P, Eshelman SH, Redinger H, Williams P, Sista ND. Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women. EClinicalMedicine. 2020 Apr 06;21:100303. doi: 10.1016/j.eclinm.2020.100303. eCollection 2020 Apr. PMID: 32280940; PMCID: PMC7139112.
Copy Download .nbib Format: NLM
Influence of Temperature and Seed Ripening on the in-vivo Incorporation of CO(2) into the Lipids of Oat Grains (Avena sativa L.).

Plant physiology

Beringer H.
PMID: 16657814
Plant Physiol. 1971 Oct;48(4):433-6. doi: 10.1104/pp.48.4.433.

To elucidate the influence of growth temperature and of stage of maturity on lipid synthesis in seeds, oat plants (Avena sativa nuda L., variety NOS) were fed with (14)CO(2) at different stages after flowering, and the (14)C-incorporation into the...

Cite
Beringer H. Influence of Temperature and Seed Ripening on the in-vivo Incorporation of CO(2) into the Lipids of Oat Grains (Avena sativa L.). Plant Physiol. 1971;48(4):433-6doi: 10.1104/pp.48.4.433.
Beringer, H. (1971). Influence of Temperature and Seed Ripening on the in-vivo Incorporation of CO(2) into the Lipids of Oat Grains (Avena sativa L.). Plant physiology, 48(4), 433-6. https://doi.org/10.1104/pp.48.4.433
Beringer, H. "Influence of Temperature and Seed Ripening on the in-vivo Incorporation of CO(2) into the Lipids of Oat Grains (Avena sativa L.)." Plant physiology vol. 48,4 (1971): 433-6. doi: https://doi.org/10.1104/pp.48.4.433
Beringer H. Influence of Temperature and Seed Ripening on the in-vivo Incorporation of CO(2) into the Lipids of Oat Grains (Avena sativa L.). Plant Physiol. 1971 Oct;48(4):433-6. doi: 10.1104/pp.48.4.433. PMID: 16657814; PMCID: PMC396882.
Copy Download .nbib Format: NLM
Immature maize spikelets develop and produce pollen in culture.

Plant cell reports

Stapleton AE, Bedinger PA.
PMID: 24203133
Plant Cell Rep. 1992 Jun;11(5):248-52. doi: 10.1007/BF00235075.

Immature maize spikelets have been successfully grown in vitro. Culture conditions were refined to maximize development of normal pollen grains. Kinetin was not required for normal development, in contrast to the absolute requirement for this plant growth regulator for...

Cite
Stapleton AE, Bedinger PA. Immature maize spikelets develop and produce pollen in culture. Plant Cell Rep. 1992;11(5):248-52doi: 10.1007/BF00235075.
Stapleton, A. E., & Bedinger, P. A. (1992). Immature maize spikelets develop and produce pollen in culture. Plant cell reports, 11(5), 248-52. https://doi.org/10.1007/BF00235075
Stapleton, A E, and Bedinger, P A. "Immature maize spikelets develop and produce pollen in culture." Plant cell reports vol. 11,5 (1992): 248-52. doi: https://doi.org/10.1007/BF00235075
Stapleton AE, Bedinger PA. Immature maize spikelets develop and produce pollen in culture. Plant Cell Rep. 1992 Jun;11(5):248-52. doi: 10.1007/BF00235075. PMID: 24203133.
Copy Download .nbib Format: NLM
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.

Frontiers in immunology

Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J.
PMID: 34759930
Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021.

γδT cell receptors (γδTCRs) recognize a broad range of malignantly transformed cells in mainly a major histocompatibility complex (MHC)-independent manner, making them valuable additions to the engineered immune effector cell therapy that currently focuses primarily on αβTCRs and chimeric...

Cite
Johanna I, Hernández-López P, Heijhuurs S, et al. Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Front Immunol. 2021;12:752699doi: 10.3389/fimmu.2021.752699.
Johanna, I., Hernández-López, P., Heijhuurs, S., Scheper, W., Bongiovanni, L., de Bruin, A., Beringer, D. X., Oostvogels, R., Straetemans, T., Sebestyen, Z., & Kuball, J. (2021). Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Frontiers in immunology, 12752699. https://doi.org/10.3389/fimmu.2021.752699
Johanna, Inez, et al. "Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control." Frontiers in immunology vol. 12 (2021): 752699. doi: https://doi.org/10.3389/fimmu.2021.752699
Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J. Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021. PMID: 34759930; PMCID: PMC8573335.
Copy Download .nbib Format: NLM
N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants.

American journal of medical genetics. Part A

Charron JG, Hernandez A, Bilinovich SM, Vogt DL, Bedinger LA, Seaver LH, Williams M, Devries S, Campbell DB, Bupp CP, Prokop JW.
PMID: 34726335
Am J Med Genet A. 2021 Nov 02; doi: 10.1002/ajmg.a.62554. Epub 2021 Nov 02.

Predicting genotype-to-phenotype correlations from genomic variants has been challenging, particularly for genes that have a complex balance of dominant and recessive inheritance for phenotypes. Variants in NMDA receptor components GRIN1, GRIN2A, and GRIN2B cause a myriad of dominant disease...

Cite
Charron JG, Hernandez A, Bilinovich SM, et al. N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants. Am J Med Genet A. 2021;doi: 10.1002/ajmg.a.62554.
Charron, J. G., Hernandez, A., Bilinovich, S. M., Vogt, D. L., Bedinger, L. A., Seaver, L. H., Williams, M., Devries, S., Campbell, D. B., Bupp, C. P., & Prokop, J. W. (2021). N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants. American journal of medical genetics. Part A, . https://doi.org/10.1002/ajmg.a.62554
Charron, Jacob G, et al. "N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants." American journal of medical genetics. Part A vol. (2021). doi: https://doi.org/10.1002/ajmg.a.62554
Charron JG, Hernandez A, Bilinovich SM, Vogt DL, Bedinger LA, Seaver LH, Williams M, Devries S, Campbell DB, Bupp CP, Prokop JW. N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants. Am J Med Genet A. 2021 Nov 02; doi: 10.1002/ajmg.a.62554. Epub 2021 Nov 02. PMID: 34726335.
Copy Download .nbib Format: NLM
Building community resilience in a context of climate change: The role of social capital.

Ambio

Carmen E, Fazey I, Ross H, Bedinger M, Smith FM, Prager K, McClymont K, Morrison D.
PMID: 35015248
Ambio. 2022 Jan 11; doi: 10.1007/s13280-021-01678-9. Epub 2022 Jan 11.

Social capital is considered important for resilience across social levels, including communities, yet insights are scattered across disciplines. This meta-synthesis of 187 studies examines conceptual and empirical understandings of how social capital relates to resilience, identifying implications for community...

Cite
Carmen E, Fazey I, Ross H, et al. Building community resilience in a context of climate change: The role of social capital. Ambio. 2022;doi: 10.1007/s13280-021-01678-9.
Carmen, E., Fazey, I., Ross, H., Bedinger, M., Smith, F. M., Prager, K., McClymont, K., & Morrison, D. (2022). Building community resilience in a context of climate change: The role of social capital. Ambio, . https://doi.org/10.1007/s13280-021-01678-9
Carmen, Esther, et al. "Building community resilience in a context of climate change: The role of social capital." Ambio vol. (2022). doi: https://doi.org/10.1007/s13280-021-01678-9
Carmen E, Fazey I, Ross H, Bedinger M, Smith FM, Prager K, McClymont K, Morrison D. Building community resilience in a context of climate change: The role of social capital. Ambio. 2022 Jan 11; doi: 10.1007/s13280-021-01678-9. Epub 2022 Jan 11. PMID: 35015248.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in genetics

Broz AK, Miller CM, Baek YS, Tovar-Méndez A, Acosta-Quezada PG, Riofrío-Cuenca TE, Rusch DB, Bedinger PA.
PMID: 34938321
Front Genet. 2021 Dec 06;12:780793. doi: 10.3389/fgene.2021.780793. eCollection 2021.

The self-incompatibility (SI) system in the Solanaceae is comprised of cytotoxic pistil S-RNases which are countered by S-locus F-box (SLF) resistance factors found in pollen. Under this barrier-resistance architecture, mating system transitions from SI to self-compatibility (SC) typically result...

Cite
Broz AK, Miller CM, Baek YS, et al. . Front Genet. 2021;12:780793doi: 10.3389/fgene.2021.780793.
Broz, A. K., Miller, C. M., Baek, Y. S., Tovar-Méndez, A., Acosta-Quezada, P. G., Riofrío-Cuenca, T. E., Rusch, D. B., & Bedinger, P. A. (2021). . Frontiers in genetics, 12780793. https://doi.org/10.3389/fgene.2021.780793
Broz, Amanda K, et al. "." Frontiers in genetics vol. 12 (2021): 780793. doi: https://doi.org/10.3389/fgene.2021.780793
Broz AK, Miller CM, Baek YS, Tovar-Méndez A, Acosta-Quezada PG, Riofrío-Cuenca TE, Rusch DB, Bedinger PA. . Front Genet. 2021 Dec 06;12:780793. doi: 10.3389/fgene.2021.780793. eCollection 2021. PMID: 34938321; PMCID: PMC8685505.
Copy Download .nbib Format: NLM
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.

Frontiers in immunology

Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J.
PMID: 34759930
Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021.

γδT cell receptors (γδTCRs) recognize a broad range of malignantly transformed cells in mainly a major histocompatibility complex (MHC)-independent manner, making them valuable additions to the engineered immune effector cell therapy that currently focuses primarily on αβTCRs and chimeric...

Cite
Johanna I, Hernández-López P, Heijhuurs S, et al. Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Front Immunol. 2021;12:752699doi: 10.3389/fimmu.2021.752699.
Johanna, I., Hernández-López, P., Heijhuurs, S., Scheper, W., Bongiovanni, L., de Bruin, A., Beringer, D. X., Oostvogels, R., Straetemans, T., Sebestyen, Z., & Kuball, J. (2021). Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Frontiers in immunology, 12752699. https://doi.org/10.3389/fimmu.2021.752699
Johanna, Inez, et al. "Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control." Frontiers in immunology vol. 12 (2021): 752699. doi: https://doi.org/10.3389/fimmu.2021.752699
Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J. Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control. Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021. PMID: 34759930; PMCID: PMC8573335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries